Orchid Pharma Limited
UTI Mutual Fund marginally reduced its stake in Orchid Pharma from 3.10% to 3.09%, selling 6,055 shares.
A pharmaceutical manufacturer focused on active pharmaceutical ingredients and finished dosage forms, Orchid Pharma develops and produces medicines for domestic and international markets. The company operates across API manufacturing, formulation development, and new drug research, serving healthcare providers and patients through a vertically integrated approach. Its distinctive strength lies in combining chemical synthesis capabilities with drug discovery efforts to deliver therapeutic solutions across multiple therapeutic areas.
India's oldest and most storied asset manager, founded in 1963 as the Unit Trust of India under an Act of Parliament. Now manages over Rs 3.5 lakh crore with backing from four public sector institutions: LIC, SBI, Bank of Baroda, and Punjab National Bank. CIO Vetri Subramaniam is a long-term compounder with a consistent quality tilt and clear articulation of process.